NEW YORK (GenomeWeb) – Biocartis said today that it is collaborating with medical research charity MRC Technology to develop molecular diagnostic tests for use on the Biocartis fully automated Idylla platform.

Under the terms of the agreement, MRCT will act as a development contractor and Biocartis will be responsible for the commercialization of the tests under its own label. Financial details of the partnership were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.